These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 12673200

  • 1. Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I.
    Ayrault O, Karayan L, Riou JF, Larsen CJ, Séité P.
    Oncogene; 2003 Apr 03; 22(13):1945-54. PubMed ID: 12673200
    [Abstract] [Full Text] [Related]

  • 2. Human ARF protein interacts with topoisomerase I and stimulates its activity.
    Karayan L, Riou JF, Séité P, Migeon J, Cantereau A, Larsen CJ.
    Oncogene; 2001 Feb 15; 20(7):836-48. PubMed ID: 11314011
    [Abstract] [Full Text] [Related]

  • 3. p14ARF interacts with N-Myc and inhibits its transcriptional activity.
    Amente S, Gargano B, Diolaiti D, Della Valle G, Lania L, Majello B.
    FEBS Lett; 2007 Mar 06; 581(5):821-5. PubMed ID: 17289033
    [Abstract] [Full Text] [Related]

  • 4. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.
    Greenblatt MS, Beaudet JG, Gump JR, Godin KS, Trombley L, Koh J, Bond JP.
    Oncogene; 2003 Feb 27; 22(8):1150-63. PubMed ID: 12606942
    [Abstract] [Full Text] [Related]

  • 5. Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus.
    Lindström MS, Klangby U, Inoue R, Pisa P, Wiman KG, Asker CE.
    Exp Cell Res; 2000 May 01; 256(2):400-10. PubMed ID: 10772813
    [Abstract] [Full Text] [Related]

  • 6. Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes.
    Ayrault O, Andrique L, Larsen CJ, Seite P.
    Oncogene; 2004 Oct 21; 23(49):8097-104. PubMed ID: 15361825
    [Abstract] [Full Text] [Related]

  • 7. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B, Lewis WS, DiGiammarino EL, Weber JD, Bothner SJ, Kriwacki RW.
    J Mol Biol; 2001 Nov 23; 314(2):263-77. PubMed ID: 11718560
    [Abstract] [Full Text] [Related]

  • 8. Simian virus 40 large T antigen binds to topoisomerase I.
    Simmons DT, Melendy T, Usher D, Stillman B.
    Virology; 1996 Aug 15; 222(2):365-74. PubMed ID: 8806520
    [Abstract] [Full Text] [Related]

  • 9. RRM proteins interacting with the cap region of topoisomerase I.
    Trzcińska-Daneluti AM, Górecki A, Czubaty A, Kowalska-Loth B, Girstun A, Murawska M, Lesyng B, Staroń K.
    J Mol Biol; 2007 Jun 15; 369(4):1098-112. PubMed ID: 17481653
    [Abstract] [Full Text] [Related]

  • 10. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.
    Rutter JL, Goldstein AM, Dávila MR, Tucker MA, Struewing JP.
    Oncogene; 2003 Jul 10; 22(28):4444-8. PubMed ID: 12853981
    [Abstract] [Full Text] [Related]

  • 11. The p14ARF alternate reading frame protein enhances DNA binding of topoisomerase I by interacting with the serine 506-phosphorylated core domain.
    Bandyopadhyay K, Li P, Gjerset RA.
    PLoS One; 2013 Jul 10; 8(3):e58835. PubMed ID: 23555599
    [Abstract] [Full Text] [Related]

  • 12. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y, Yamamoto H, Takahira T, Kobayashi C, Kawaguchi K, Tateishi N, Nozuka Y, Tamiya S, Tanaka K, Matsuda S, Yokoyama R, Iwamoto Y, Tsuneyoshi M.
    J Pathol; 2005 Dec 10; 207(4):410-21. PubMed ID: 16177957
    [Abstract] [Full Text] [Related]

  • 13. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N, De Marco MF, Martelli MP, Bigerna B, Pucciarini A, Rossi R, Mannucci R, Manes N, Pettirossi V, Pileri SA, Nicoletti I, Falini B.
    Leukemia; 2009 Mar 10; 23(3):501-9. PubMed ID: 19005479
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T, Nakao K.
    J Gastroenterol; 2004 Mar 10; 39(4):355-61. PubMed ID: 15168247
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 18. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
    Hemmati PG, Normand G, Verdoodt B, von Haefen C, Hasenjäger A, Güner D, Wendt J, Dörken B, Daniel PT.
    Oncogene; 2005 Jun 09; 24(25):4114-28. PubMed ID: 15750619
    [Abstract] [Full Text] [Related]

  • 19. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.
    Suzuki H, Kurita M, Mizumoto K, Moriyama M, Aiso S, Nishimoto I, Matsuoka M.
    Biochem Biophys Res Commun; 2005 Jan 07; 326(1):242-8. PubMed ID: 15567177
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
    Kim M, Sgagias M, Deng X, Jung YJ, Rikiyama T, Lee K, Ouellette M, Cowan K.
    Biochem Biophys Res Commun; 2004 Jul 16; 320(1):138-44. PubMed ID: 15207713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.